Literature DB >> 17556861

Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis.

Y Toledano1, A Lubetsky, I Shimon.   

Abstract

UNLABELLED: Acquired PRL deficiency occurs when the anterior pituitary is functionally destroyed, and it usually accompanies other pituitary hormone deficiencies. We retrospectively investigated in an outpatient endocrine clinic of a major tertiary medical center the prevalence and clinical characteristics of acquired PRL deficiency in patients with diseases of the hypothalamic-pituitary axis. The study included 100 consecutive patients, 61 men and 39 women, aged 4-79 yr at diagnosis. Patients were divided by PRL level to normal (>5 ng/ml), mild (3-5 ng/ml), and severe deficiency (<3 ng/ml). Twenty-seven patients (27%) had PRL deficiency, 13 mild deficiency and 14 severe deficiency. Patients with severe PRL deficiency tend to be younger at diagnosis (mean age, 37.5+/-21.8 yr) than patients with normal PRL (46+/-18.5 yr; ns). Underlying diseases including pituitary apoplexy, non-functioning pituitary adenoma, craniopharyngioma, and idiopathic hypogonadotropic hypogonadism were associated with PRL deficiency. The incidence of severe PRL deficiency rose with an increase in the number of other pituitary hormone deficits (ACTH, TSH, gonadotropin, vasopressin), from 0 in patients with no other deficits to 38% in patients with 4 deficits (p=0.006). Patients with severe deficiency had a mean of 3 hormone deficits compared to 1.8 in the other groups (p=0.006). PRL deficiency was significantly associated with TSH, ACTH and GH deficiency.
CONCLUSIONS: PRL deficiency is common in patients with hypothalamic-pituitary disorders, especially pituitary apoplexy and craniopharyngioma. Acquired severe PRL deficiency can be considered a marker for extensive pituitary damage and a more severe degree of hypopituitarism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556861     DOI: 10.1007/BF03346292

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  A woman with isolated prolactin deficiency.

Authors:  T Douchi; M Nakae; S Yamamoto; I Iwamoto; T Oki; Y Nagata
Journal:  Acta Obstet Gynecol Scand       Date:  2001-04       Impact factor: 3.636

2.  GH deficiency in adults: an epidemiological approach.

Authors:  G Sassolas; F B Chazot; P Jaquet; I Bachelot; P Chanson; C C Rudelli; J P Tauber; H Allannic; J Bringer; N Roudaut; V Rohmer; P Roger; J L Latapie; P Reville; M Leutenegger
Journal:  Eur J Endocrinol       Date:  1999-12       Impact factor: 6.664

3.  Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis.

Authors:  Annice Mukherjee; Robert D Murray; Breeda Columb; Helena K Gleeson; Stephen M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  2003-12       Impact factor: 3.478

Review 4.  Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects.

Authors:  N Ben-Jonathan; J L Mershon; D L Allen; R W Steinmetz
Journal:  Endocr Rev       Date:  1996-12       Impact factor: 19.871

5.  The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas.

Authors:  B M Arafah; D Prunty; J Ybarra; M L Hlavin; W R Selman
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

6.  Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function.

Authors:  Dany H Zayour; Warren R Selman; Baha M Arafah
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

7.  Clinical report of 28 patients with Sheehan's syndrome.

Authors:  Murat Sert; Tamer Tetiker; Sinan Kirim; Mustafa Kocak
Journal:  Endocr J       Date:  2003-06       Impact factor: 2.349

8.  Isolated prolactin deficiency: a case report.

Authors:  R J Falk
Journal:  Fertil Steril       Date:  1992-11       Impact factor: 7.329

9.  Differential effects of prolactin upon activation and differentiation of human B lymphocytes.

Authors:  N Lahat; A Miller; R Shtiller; E Touby
Journal:  J Neuroimmunol       Date:  1993-08       Impact factor: 3.478

10.  Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia.

Authors:  R W Pfäffle; G E DiMattia; J S Parks; M R Brown; J M Wit; M Jansen; H Van der Nat; J L Van den Brande; M G Rosenfeld; H A Ingraham
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

View more
  4 in total

Review 1.  Management of craniopharyngiomas.

Authors:  N Karavitaki
Journal:  J Endocrinol Invest       Date:  2014-03       Impact factor: 4.256

2.  The pituitary stalk effect: is it a passing phenomenon?

Authors:  Marvin Bergsneider; Leili Mirsadraei; William H Yong; Noriko Salamon; Michael Linetsky; Marilene B Wang; David L McArthur; Anthony P Heaney
Journal:  J Neurooncol       Date:  2014-02-19       Impact factor: 4.130

Review 3.  Hyperprolactinemia.

Authors:  Jaspreet Chahal; Janet Schlechte
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

4.  Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells.

Authors:  Shintaro Iwama; Corrine K Welt; Christopher J Romero; Sally Radovick; Patrizio Caturegli
Journal:  J Clin Endocrinol Metab       Date:  2013-08-12       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.